Creatine Supplementation for Health and Clinical Diseases

Creatine plays a critical role in cellular metabolism, primarily by binding with phosphate to form phosphocreatine (PCr) as well as shuttling high-energy phosphate compounds in and out of the mitochondria for metabolism. Increasing the dietary availability of creatine increases the tissue and cellul...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2022
Language:English
Physical Description:1 electronic resource (562 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 07965nam-a2202257z--4500
001 993545099904498
005 20231214133517.0
006 m o d
007 cr|mn|---annan
008 202205s2022 xx |||||o ||| 0|eng d
035 |a (CKB)5680000000037619 
035 |a (oapen)https://directory.doabooks.org/handle/20.500.12854/81102 
035 |a (EXLCZ)995680000000037619 
041 0 |a eng 
100 1 |a Kreider, Richard B.  |4 edt 
245 1 0 |a Creatine Supplementation for Health and Clinical Diseases 
260 |a Basel  |b MDPI - Multidisciplinary Digital Publishing Institute  |c 2022 
300 |a 1 electronic resource (562 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
520 |a Creatine plays a critical role in cellular metabolism, primarily by binding with phosphate to form phosphocreatine (PCr) as well as shuttling high-energy phosphate compounds in and out of the mitochondria for metabolism. Increasing the dietary availability of creatine increases the tissue and cellular availability of PCr, and thereby enhances the ability to maintain high-energy states during intense exercise. For this reason, creatine monohydrate has been extensively studied as an ergogenic aid for exercise, training, and sport. Limitations in the ability to synthesize creatine and transport and/or store dietary creatine can impair metabolism and is a contributor to several disease states. Additionally, creatine provides an important source of energy during metabolically stressed states, particularly when oxygen availability is limited. Thus, researchers have assessed the role of creatine supplementation on health throughout the lifespan, as well as whether creatine availability may improve disease management and/or therapeutic outcomes. This book provides a comprehensive overview of scientific and medical evidence related to creatine's role in metabolism, health throughout the lifespan, and our current understanding of how creatine can promote brain, heart, vascular and immune health; reduce the severity of musculoskeletal and brain injury; and may provide therapeutic benefits in glucose management and diabetes, cancer therapy, inflammatory bowel disease, and post-viral fatigue. 
546 |a English 
650 7 |a Research & information: general  |2 bicssc 
650 7 |a Biology, life sciences  |2 bicssc 
650 7 |a Food & society  |2 bicssc 
653 |a ergogenic aids 
653 |a cellular metabolism 
653 |a phosphagens 
653 |a sarcopenia 
653 |a cognition 
653 |a diabetes 
653 |a creatine synthesis deficiencies 
653 |a concussion 
653 |a traumatic brain injury 
653 |a spinal cord injury 
653 |a muscle atrophy 
653 |a rehabilitation 
653 |a pregnancy 
653 |a immunity 
653 |a anti-inflammatory 
653 |a antioxidant 
653 |a anticancer 
653 |a creatine 
653 |a nutritional supplements 
653 |a fertility 
653 |a newborn 
653 |a development 
653 |a brain injury 
653 |a post-viral fatigue syndrome 
653 |a chronic fatigue syndrome 
653 |a GAA 
653 |a creatine kinase 
653 |a dietary supplements 
653 |a exercise 
653 |a skeletal muscle 
653 |a glycemic control 
653 |a type 2 diabetes mellitus 
653 |a phosphorylcreatine 
653 |a dietary supplement 
653 |a ergogenic aid 
653 |a youth 
653 |a athletes 
653 |a osteoporosis 
653 |a osteosarcopenia 
653 |a frailty 
653 |a cachexia 
653 |a innate immunity 
653 |a adaptive immunity 
653 |a inflammation 
653 |a macrophage polarization 
653 |a cytotoxic T cells 
653 |a toll-like receptors 
653 |a vascular pathology 
653 |a cardiovascular disease 
653 |a oxidative stress 
653 |a vascular health 
653 |a female 
653 |a menstrual cycle 
653 |a hormones 
653 |a exercise performance 
653 |a menopause 
653 |a mood 
653 |a children 
653 |a height 
653 |a BMI-for-age 
653 |a stature-for-age 
653 |a growth 
653 |a phosphocreatine 
653 |a creatine transporter 
653 |a supplementation 
653 |a treatment 
653 |a heart 
653 |a heart failure 
653 |a ischemia 
653 |a myocardial infarction 
653 |a anthracycline 
653 |a cardiac toxicity 
653 |a energy metabolism 
653 |a cell survival 
653 |a bioinformatics 
653 |a systems biology 
653 |a cellular allostasis 
653 |a dynamic biosensor 
653 |a pleiotropic effects of creatine (Cr) supplementation 
653 |a inflammatory bowel diseases (IBD) 
653 |a ulcerative colitis 
653 |a Crohn’s disease 
653 |a creatine kinase (CK) 
653 |a phosphocreatine (PCr) 
653 |a creatine transporter (CrT) 
653 |a intestinal epithelial cell protection 
653 |a intestinal tissue protection 
653 |a creatine perfusion 
653 |a organ transplantation 
653 |a Adenosine mono-phosphate (AMP) 
653 |a activated protein kinase (AMPK) 
653 |a liver kinase B1 (LKB1) 
653 |a mitochondrial permeability transition pore (mPTP) 
653 |a reactive oxygen species (ROS) 
653 |a glucose transporter (GLUT) 
653 |a T cell antitumor immunity 
653 |a metabolic regulator 
653 |a cancer immunotherapy 
653 |a supplements 
653 |a muscle damage 
653 |a recovery 
653 |a immobilization 
653 |a atrophy 
653 |a muscular dystrophy 
653 |a amyotrophic lateral sclerosis 
653 |a Parkinson’s Disease 
653 |a cardiopulmonary disease 
653 |a mitochondrial cytopathy 
653 |a hypertrophy 
653 |a athletic performance 
653 |a weightlifting 
653 |a resistance exercise 
653 |a training 
653 |a muscular power 
653 |a muscular adaptation 
653 |a muscle fatigue 
653 |a adipose tissue 
653 |a muscle strength 
653 |a physiological adaptation 
653 |a mitochondria 
653 |a thermogenesis 
653 |a MAP kinase signaling system 
653 |a sodium-chloride-dependent neurotransmitter symporters 
653 |a signal transduction 
653 |a intradialytic creatine supplementation 
653 |a hemodialysis 
653 |a muscle 
653 |a protein energy wasting 
653 |a clinical trial 
653 |a muscle weakness 
653 |a chronic fatigue 
653 |a cognitive impairment 
653 |a depression 
653 |a anemia 
653 |a resistance training 
653 |a sports nutrition 
653 |a strength 
653 |a toxicity 
653 |a methylation 
653 |a hyperhomocysteinemia 
653 |a neuromodulation 
653 |a MCDA 
653 |a mitochondriopathia 
653 |a cardiac infarction 
653 |a long COVID 
653 |a hypoxia 
653 |a stroke 
653 |a neurodegenerative diseases 
653 |a noncommunicable disease 
653 |a adenosine 5′-monopnophosphate-activated protein kinase 
653 |a anthracyclines 
653 |a creatine supplementation 
653 |a cardiac signaling 
653 |a cardiotoxicity 
653 |a doxorubicin 
653 |a soy 
653 |a vegetarian/vegan diet 
653 |a amino acids 
653 |a dietary ingredients 
653 |a performance 
776 |z 3-0365-2155-0 
776 |z 3-0365-2156-9 
700 1 |a Stout, Jeffrey  |4 edt 
700 1 |a Kreider, Richard B.  |4 oth 
700 1 |a Stout, Jeffrey  |4 oth 
906 |a BOOK 
ADM |b 2023-12-15 05:56:17 Europe/Vienna  |f system  |c marc21  |a 2022-05-14 21:41:54 Europe/Vienna  |g false 
AVE |i DOAB Directory of Open Access Books  |P DOAB Directory of Open Access Books  |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337802530004498&Force_direct=true  |Z 5337802530004498  |b Available  |8 5337802530004498